Article citationsMore>>

Alhussan, A., Jackson, N., Chow, N., Gete, E., Wretham, N., Dos Santos, N., et al. (2024) In Vitro and in Vivo Synergetic Radiotherapy with Gold Nanoparticles and Docetaxel for Pancreatic Cancer. Pharmaceutics, 16, Article 713.
https://doi.org/10.3390/pharmaceutics16060713

has been cited by the following article:

• TITLE: Advancements in the Research of Gold Nanomaterials for Radiation Therapy Sensitization

  AUTHORS: Yuzhe Zhang, Xiaohui Zhao, Xin He, Shengni Hua, Yusheng Shi

  KEYWORDS: Gold Nanomaterials, Radiotherapy, Sensitization

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.12 No.11, November 28, 2024

  ABSTRACT: Gold nanomaterials exhibit unique advantages in tumor radiotherapy sensitization due to their enhanced X-ray deposition capability, excellent biocompatibility, and superior chemical, electronic, and optical properties. To date, studies on gold nanomaterial-mediated radiosensitization have been reported, with related mechanisms including catalyzing reactive oxygen species (ROS) production, depleting intracellular glutathione (GSH), overcoming tumor hypoxia, and regulating cell cycles. This article will elaborate on the research progress of gold nanomaterial-mediated tumor radiotherapy sensitization and discuss its mechanisms and future research directions. In addition, the limitations of gold nanomaterials in clinical applications will be further discussed.